BioCentury
ARTICLE | Financial News

NanoString adds $20M in series D

November 8, 2011 1:46 AM UTC

Diagnostics company NanoString Technologies Inc. (Seattle, Wash.) raised $20 million in a series D round. New investors GE healthymagination Fund; BioMed Ventures; and Henri Termeer participated. All of NanoString's existing investors also participated, including Clarus Ventures; Draper Fisher Jurvetson; and OVP Venture Partners. Termeer is the former chairman, president and CEO of Genzyme Corp., which was acquired by Sanofi (Euronext:SAN; NYSE:SNY) this year. ...